View More Recent Stories

Aug 6, 2015 04:05PM Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Second Quarter 2015 Financial Results
Jul 29, 2015 08:30AM Esperion Therapeutics to Provide Second Quarter Program Updates and Financial Results
Jul 28, 2015 12:14PM Streetinsider.com's Hot Lunchtime Reads 7/28: (TWTR) (MU) (MGM) (ESPR)
Jul 28, 2015 07:30AM Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Jul 23, 2015 04:30PM Esperion Therapeutics to Host Second Annual Analyst and Investor Day
Jul 7, 2015 08:00AM Esperion Therapeutics Announces Removal of 240 mg Partial Clinical Hold for ETC-1002
Jun 16, 2015 04:30PM Esperion Therapeutics to Present at the JMP Securities Life Science Conference
Jun 15, 2015 08:30AM Esperion Therapeutics Announces the Appointment of Scott Braunstein, M.D. to Board of Directors
May 11, 2015 04:30PM Esperion Therapeutics to Present at the UBS Global Healthcare Conference
May 7, 2015 04:05PM Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports First Quarter 2015 Financial Results
May 5, 2015 04:30PM Esperion Therapeutics to Present at Bank of America Merrill Lynch 2015 Healthcare Conference
Apr 30, 2015 04:30PM Esperion Therapeutics to Provide First Quarter 2015 Results
Apr 7, 2015 04:30PM Esperion Therapeutics to Present at 14th Annual Needham Healthcare Conference
Apr 1, 2015 11:01AM Notable Analyst Rating Changes 4/1: (HPQ) (SPLS) (CMPR) Upgraded; (AAL) (UHS) (ONNN) Downgraded
Apr 1, 2015 09:24AM Pre-Open Stock Movers 04/01: (VLTC) (DYAX) (SHLD) Higher; (CTSO) (UTIW) (MAC) Lower (more...)
Mar 17, 2015 07:30AM Esperion Therapeutics Announces Positive Top-Line Phase 2b Results for ETC-1002 Added to Stable Statin Therapy in Patients With Hypercholesterolemia
Mar 12, 2015 04:30PM Esperion Therapeutics to Present at Bank of America Merrill Lynch Smid Cap and BioCentury Future Leaders in the Biotech Industry Conferences
Mar 9, 2015 08:30AM ETC-1002-008 Phase 2b Results to be Presented at the American College of Cardiology 64th Annual Scientific Session
Mar 5, 2015 04:05PM Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Fourth Quarter and Full Year 2014 Financial Results
Oct 2, 2014 09:28AM Pre-Open Stock Movers 10/02: (ESPR) (RLD) (TSLA) Higher; (CREE) (WILN) (GPRO) Lower (more...)
View More Recent Stories